Your browser doesn't support javascript.
loading
Sorafenib as a potential strategy for refractory pulmonary arterial hypertension.
Kimura, Gou; Kataoka, Masaharu; Inami, Takumi; Fukuda, Keiichi; Yoshino, Hideaki; Satoh, Toru.
  • Kimura G; Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.
  • Kataoka M; Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan. Electronic address: m.kataoka09@keio.jp.
  • Inami T; Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.
  • Fukuda K; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Yoshino H; Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.
  • Satoh T; Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan. Electronic address: tsatoh@ks.kyorin-u.ac.jp.
Pulm Pharmacol Ther ; 44: 46-49, 2017 06.
Article en En | MEDLINE | ID: mdl-28315488

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Niacinamida / Inhibidores de Proteínas Quinasas / Hipertensión Pulmonar Primaria Familiar / Hipertensión Pulmonar Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Niacinamida / Inhibidores de Proteínas Quinasas / Hipertensión Pulmonar Primaria Familiar / Hipertensión Pulmonar Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article